MOST: Blood Thinners Lack Improvement in Ischemic Stroke Outcomes
Blood thinners added to clot-busting medication did not improve 90-day stroke outcomes, leading to early discontinuation of the MOST trial.
Source: hcplive.com
Page 2 - Multi Arm Optimization News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Multi Arm Optimization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Multi Arm Optimization Today - Breaking & Trending Today
International Stroke Conference 2024 to Present High-Profile Late-Breaking Science
The International Stroke Conference 2024 will be held Feb. 7-9 in Phoenix, Arizona. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.
Source: dicardiology.com
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial | Cerebrovascular Disease | JAMA
This randomized clinical trial examines the efficacy of argatroban plus altepase for acute ischemic stroke within 4.5 hours from onset.
Source: jamanetwork.com